Press Releases

Calgary, Alberta--(Newsfile Corp. - June 5, 2024) - Olympia Financial Group Inc. (TSX: OLY) announces that its Board of Directors has declared a monthly cash dividend on its common shares of $0.60 per common share. The dividend will be payable on June 28, 2024, to shareholders on record as at June 19, 2024. The ex-dividend date is June 19, 2024.

Olympia Financial Group Inc. designates the entire amount of this taxable dividend to be an "eligible dividend" for purposes... (continue reading...)

(The NPCC Assessment covers New York, New England, and Eastern Canada)

NEW YORK--(BUSINESS WIRE)-- The Northeast Power Coordinating Council, Inc.’s (NPCC) annual summer reliability assessment forecasts the NPCC Region will have an adequate supply of electricity this summer. The overall NPCC coincident electricity summer peak demand is forecasted to be approximately 105,000 MW, which is approximately 200 MW lower than last summer. A total installed capacity of... (continue reading...)

BOSTON--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief executive officer and David Henry, chief financial officer, will present and host one-on-one meetings with investors at the Sidoti Virtual Investor conference being held on... (continue reading...)

In honor of School Employee Appreciation Month in May, SchoolsFirst FCU recognized school employees at Los Angeles Angels vs. Kansas City Royals game on May 10

TUSTIN, Calif., June 5, 2024 /PRNewswire/ -- SchoolsFirst Federal Credit Union, the largest credit union in California and the largest serving school employees and their families, sponsored a special night to honor school employees at the Los Angeles Angels game on May 10, 2024. School employees, along with... (continue reading...)

HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it has closed its previously announced private placement for the issuance and sale of an aggregate of 1,809,955 shares of its common stock (or common stock... (continue reading...)